Bringing Personalized Therapeutic Cancer Vaccines to the world, one patient at a time. Geneos Therapeutics, a Phase 2 biotherapeutics company, is developing DNA-based personalized therapeutic cancer vaccines (PTCVs) which may serve an important role as a new immunotherapeutic paradigm for cancer. The company uses its proprietary GT-EPIC™ platform to provide every cancer patient with a custom ... Read more
